Michelle L Delco Selected Research

procollagen type II carboxy-terminal peptide

1/2020

Integrin α10β1-Selected Mesenchymal Stem Cells Mitigate the Progression of Osteoarthritis in an Equine Talar Impact Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michelle L Delco Research Topics

Disease

6	Osteoarthritis 12/2021 - 01/2017
3	Wounds and Injuries (Trauma) 01/2020 - 01/2017
1	Arthralgia (Joint Pain) 12/2021
1	Inflammation (Inflammations) 01/2020
1	Sclerosis 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Arthritis (Polyarthritis) 01/2018
1	Athletic Injuries (Sports Injuries) 01/2017
1	Ankle Injuries (Ankle Injury) 01/2017

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2020
2	Biological ProductsIBA 01/2020 - 01/2017
1	ParaffinIBA 12/2021
1	Formaldehyde (Formol)FDA Link 12/2021
1	RNA (Ribonucleic Acid)IBA 12/2021
1	lubricinIBA 01/2020
1	procollagen type II carboxy-terminal peptideIBA 01/2020
1	CollagenIBA 01/2020
1	GlycosaminoglycansIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	IntegrinsIBA 01/2020
1	Collagen Type II (Type II Collagen)IBA 01/2020
1	Dinoprostone (PGE2)FDA Link 01/2020
1	LubricantsIBA 01/2018

Therapy/Procedure

5	Therapeutics 01/2020 - 01/2017
1	Injections 12/2021